Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.
A 48-hour radiometric test for determining the drug susceptibility of Mycobacterium tuberculosis has been developed. The test is based on the measurement of 14CO2 produced by the oxidation of formate labeled with carbon-14. The test system uses 5 X 10(7) organisms in 1 ml of Middlebrook 7H9 medium plus albumin-dextrose-catalase enrichment and 1 muCi of [14C]formate. The 14CO2 produced is measured in an ionization chamber at 24-, 48-, and 72-hour intervals, with and without the addition of antituberculous drugs. Isoniazid, streptomycin, rifampin, and ethambutol were each tested at 3 concentrations by the radiometric method and the reference (agar dilution) method. Six standard strains and 21 patient isolates were compared by both methods. Production of 14CO2 was quantitatively decreased in the presence of drugs that inhibit the organism. The radiometric method requires 2 days; the agar dilution, 14 to 21 days.
D000995:Antitubercular Agents / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000096:biosynthesis; D002250:Carbon Radioisotopes; D004977:Ethambutol / Q000494:pharmacology; D005561:Formates / Q000378:metabolism; D007538:Isoniazid / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
D000995:Antitubercular Agents; D002250:Carbon Radioisotopes; D005561:Formates; D002245:Carbon Dioxide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin